J Neuroinflam 9:115 Swanson KV, Deng M, Ting JP (2019) The NLRP3 inflammasome: molecular activation and regulation to therapeutics
Inflammation resolution in the cardiovascular system: arterial hypertension, atherosclerosis, and ischemic heart disease
Review Article: Efficacy and Safety of GLP-1 Medicines for Type 2 Diabetes and Obesity Background More than 19 years after the first GLP1RA was introduced for type 2 diabetes and 10 years after its approval for obesity, innovations are expanding the use of GLP-1 medicines for metabolic disorders
Fulton MD, Najahi-Missaoui W
Furthermore, Portugal research suggests that Ipamorelin also supports better energy levels and tissue repair
Peptides like Ipamorelin and CJC-1295 are attracting interest in the UK research and health community for their potential roles in growth hormone signalling, muscle metabolism, and fat regulation